Biosyent Stock Analysis

Biosyent Stock Analysis Notes

About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of Biosyent was at this time reported as 3.22. The company last dividend was issued on the 28th of February 2025. BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells various pharmaceutical and other healthcare products in Canada and internationally. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BIOSYENT INC operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on TSX Venture Exchange. To find out more about Biosyent contact Ren Goehrum at 905 206 0013 or learn more at https://www.biosyent.com.

Biosyent Investment Alerts

Biosyent Largest EPS Surprises

View All Earnings Estimates

Biosyent Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 126.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biosyent's market, we take the total number of its shares issued and multiply it by Biosyent's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Biosyent Profitablity

The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29.

Management Efficiency

Biosyent has return on total asset (ROA) of 0.1191 % which means that it generated a profit of $0.1191 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1977 %, meaning that it created $0.1977 on every $100 dollars invested by stockholders. Biosyent's management efficiency ratios could be used to measure how well Biosyent manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.15 in 2025. Return On Capital Employed is likely to climb to 0.20 in 2025. At this time, Biosyent's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 6.8 M in 2025, whereas Other Current Assets are likely to drop slightly above 163.3 K in 2025.

Technical Drivers

As of the 1st of March, Biosyent shows the Standard Deviation of 1.18, risk adjusted performance of (0.03), and Mean Deviation of 0.7976. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Biosyent, as well as the relationship between them. Please confirm Biosyent market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Biosyent is priced correctly, providing market reflects its regular price of 11.2 per share.

Biosyent Price Movement Analysis

Biosyent Outstanding Bonds

Biosyent Predictive Daily Indicators

Biosyent Forecast Models

Biosyent's time-series forecasting models are one of many Biosyent's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biosyent's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biosyent prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biosyent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biosyent. By using and applying Biosyent Stock analysis, traders can create a robust methodology for identifying Biosyent entry and exit points for their positions.

When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.